Analystreport

Nightstar Therapeutics PLC (NASDAQ: NITE) was given a new $41.00 price target on by analysts at BMO Capital Markets. They now have a "buy" rating on the stock.

NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA  (NITE) 
Last nightstar therapeutics plc american depositary sha earnings: 11/13 01:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nightstartx.com/investor-relations